Clinical efficacy of Chaihu Shugan Powder Combined with mesalazine in treatment of moderate ulcerative colitis

WAN Zhaoxing; XIAO Qiaofeng; YE Zhen; DAI Xueli; ZHENG Kaijie; YE Jing

doi:10.16025/j.1674-1307.2024.11.008

您当前的位置：

首页 >

文章列表页 >

Clinical efficacy of Chaihu Shugan Powder Combined with mesalazine in treatment of moderate ulcerative colitis

更新时间：2024-12-23

- Clinical efficacy of Chaihu Shugan Powder Combined with mesalazine in treatment of moderate ulcerative colitis
- Beijing Journal of Traditional Chinese Medicine Vol. 43, Issue 11, Pages: 1262-1265(2024)
- 作者机构：
  
  1.江西中医药大学研究生院，南昌 330004
  2.江西中医药大学临床医学院，南昌 330004
  3.江西中医药大学;附属医院消化二科，南昌 330006
- 作者简介：
- 基金信息：
- DOI：10.16025/j.1674-1307.2024.11.008
  CLC：
- Published：25 November 2024，
  
  Received：26 November 2023，
- 稿件说明：
移动端阅览
万朝星，肖乔枫，叶祯，等.柴胡疏肝散联合美沙拉嗪治疗中度溃疡性结肠炎临床观察［J］.北京中医药，2024，43（11）：1262-1265.

WAN Zhaoxing,XIAO Qiaofeng,YE Zhen,et al.Clinical efficacy of Chaihu Shugan Powder Combined with mesalazine in treatment of moderate ulcerative colitis[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(11):1262-1265.
万朝星，肖乔枫，叶祯，等.柴胡疏肝散联合美沙拉嗪治疗中度溃疡性结肠炎临床观察［J］.北京中医药，2024，43（11）：1262-1265. DOI： 10.16025/j.1674-1307.2024.11.008.

WAN Zhaoxing,XIAO Qiaofeng,YE Zhen,et al.Clinical efficacy of Chaihu Shugan Powder Combined with mesalazine in treatment of moderate ulcerative colitis[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(11):1262-1265. DOI： 10.16025/j.1674-1307.2024.11.008.

摘要

目的

观察柴胡疏肝散联合美沙拉嗪对中度溃疡性结肠炎（UC）患者焦虑抑郁状态、症状及生存质量的影响。

方法

选取2018年1月—2022年12月在江西中医药大学附属医院就诊的UC患者137例，根据治疗方案即是否服用柴胡疏肝散分为对照组82例、观察组55例进行回顾性研究。对照组给予美沙拉嗪口服，2 g/次，3次/d。观察组在对照组基础上联合中药柴胡疏肝散，1袋/次，2次/d。14 d为1个疗程，共2个疗程。对比2组治疗前后汉密尔顿焦虑量表（HAMA）评分、汉密尔顿抑郁量表（HAMD）评分、改良Mayo评分、炎症性肠病问卷调查（IBDQ）评分。

结果

治疗后，2组HAMA、HAMD评分均较治疗前降低（

0.05），且观察组低于对照组（

0.05）。2组Mayo、IBDQ评分均较治疗前改善（

0.05），且观察组优于对照组（

0.05）。

结论

柴胡疏肝散联合美沙拉嗪可显著改善中度UC患者焦虑抑郁状态、症状及生存质量，效果优于单用美沙拉嗪治疗。

Abstract

Objective

To observe the effect of Chaihu Shulang Powder combined with mesalazine on the anxiety-depression status， symptoms， and quality of life in patients with moderate ulcerative colitis （UC）.

Methods

A retrospective study was conducted on 137 UC patients who were treated at the Affiliated Hospital of Jiangxi University of Chinese Medicine from January 2018 to December 2022. According to the treatment plan， patients were divided into two groups： the control group （82 cases） and the observation group （55 cases）. The control group was treated with oral mesalazine （2 g per dose， 3 times per day）. The observation group received the same mesalazine treatment， with the addition of Chaihu Shulang Powder （1 packet per dose， 2 times per day）. One treatment course lasted 14 days， and the total treatment duration was 2 courses. The Hamilton Anxiety Scale （HAMA）， Hamilton Depression Scale （HAMD）， Modified Mayo Score， and Inflammatory Bowel Disease Questionnaire （IBDQ） scores were compared between the two groups before and after treatment.

Results

After treatment， both the HAMA and HAMD scores decreased in both groups（

0.05）， with the observation group showing significantly lower scores than the control group（

0.05）. The Mayo and IBDQ scores also improved in both groups（

0.05）， with the observation group showing better results than the control group（

0.05）.

Conclusion

Chaihu Shulang Powder combined with mesalazine can significantly improve the anxiety-depression status， symptoms， and quality of life in patients with moderate UC， and its effect is superior to mesalazine treatment alone.

关键词

溃疡性结肠炎柴胡疏肝散美沙拉嗪生存质量焦虑抑郁

Keywords

Ulcerative colitisChaihu Shugan Powdermesalazinequality of lifeanxietydepression

references

NG SC, SHI HY, HAMIDI N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies[J]. Lancet, 2017,390(10114):2769-2778.

OUYANG Q, TANDON R, GOH KL, et al. Management consensus of inflammatory bowel disease for the Asia-Pacific region[J]. J Gastroenterol Hepatol, 2006,21(12):1772-1782.

匡琪,王爱祥,向瑶.心理因素、肠道菌群、环境与溃疡性结肠炎发病的关系分析[J].中国卫生统计,2021,38(5):742-745,749.

NAVABI S, GORREPATI VS, YADAV S, et al. Influences and impact of anxiety and depression in the setting of inflammatory bowel disease[J]. Inflamm Bowel Dis, 2018,24(11):2303-2308.

GAO X, TANG Y, LEI N, et al. Symptoms of anxiety/depression is associated with more aggressive inflammatory bowel disease[J]. Sci Rep, 2021,11(1):1440.

吴开春,梁洁,冉志华,等.炎症性肠病诊断与治疗的共识意见(2018年·北京)[J].中国实用内科杂志,2018,38(9):796-813.

张景岳.景岳全书[M].太原：山西科学技术出版社,2006:782.

金玲,杨钦河,张玉佩,等.疏肝健脾方药对非酒精性脂肪性肝炎大鼠肝组织TNF-α、IL-6及IL-1的影响[J].暨南大学学报(自然科学与医学版),2012,33(2):161-166.

蒋华,武国营,蒋荣伟.柴胡疏肝散联合美沙拉秦肠溶片治疗溃疡性结肠炎的疗效及对炎症因子及血流动力学指标的影响[J].血栓与止血学,2020,26(5):745-747.

张明园，何燕玲.精神科评定量表手册[M].长沙:湖南科学技术出版社,2015：182-183.

沈洪,唐志鹏,唐旭东,等.消化系统常见病溃疡性结肠炎中医诊疗指南（基层医生版）[J].中华中医药杂志,2019,34(9):4155-4160.

欧阳钦.溃疡性结肠炎临床诊断指南[J].临床消化病杂志,2007,19(1):4-6.

FEUERSTEIN JD, ISAACS KL, SCHNEIDER Y, et al. AGA clinical practice guidelines on the management of moderate to severe ulcerative colitis[J]. Gastroenterology, 2020,158(5):1450-1461.

HAMILTON M. The assessment of anxiety states by rating[J]. BrJ Med Psychol, 1959,32(1):50-55.

HAMILTON M. A rating scale for depression[J]. J Neurol Neurosurg Psychiatry,1960,23:56-62.

李军祥,陈誩.溃疡性结肠炎中西医结合诊疗共识意见(2017年)[J].中国中西医结合消化杂志,2018,26(2):105-111,120.

MANCINA RM， PAGNOTTA R， PAGLIUSO C， et al. Gastrointestinal symptoms of and psychosocial changes in inflammatory bowel disease: a nursing-led cross-sectional study of patients in clinical remission[J]. Medicina (Kaunas， Lithuania)， 2020，56(1):1-9.

GRACIE DJ， GUTHRIE EA， HAMLIN PJ， et al. Bi-directionality of brain-gut interactions in patients with inflammatory bowel disease[J]. Gastroenterology， 2018，154(6):1635-1646,e3.

周瑾,黄菲,吴晓俊.柴胡疏肝散抗抑郁化学成分和药理作用研究进展[J].中药药理与临床,2019,35(2):174-179.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Mechanism of Baitouweng Decoction in alleviating ulcerative colitis via signaling pathways

Study on the regulatory effect of Yuxian Formula on retention enema on PXR/NF-κB signaling pathway and inflammatory factors in rats with ulcerative colitis of damp-heat type in large intestine

Effect and mechanism of Qingre Jianpi Tiaochang Recipe in DSS-induced colitis model mice

Mechanism of Rhizoma coptidis in improving diarrhea in ulcerative colitis through regulating the expression of AQPs protein in colonic mucosal epithelial cells

Effect of Qingre Huashi Quyu Recipe on intestinal flora in patients with mild to moderate ulcerative colitis

Related Author

WEI Wei

ZHANG Yiqing

SUN Weiqi

YANG Zhen-bin

WANG Qing-na

YANG Chao

QIU Wei

CHEN Li-li

Related Institution

Department of Spleen and Stomach Diseases （Digestion）， Wangjing Hospital， China Academy of Chinese Medical Sciences

Spleen and Stomach Diseases Department， Yangzhou Hospital Affiliated to Nanjing University of Traditional Chinese Medicine

Department of Spleen and Stomach Diseases， Wangjing Hospital， China Academy of Chinese Medical Sciences， Beijing Key Laboratory of TCM Diagnosis and Treatment of Functional Gastrointestinal Diseases

Institute of Clinical Basic Medicine of Traditional Chinese Medicine， China Academy of Chinese Medical Sciences

Department of Gastroenterology，the Second Affiliated Hospital of Guangzhou University of Chinese Medicine

⁰